SCAT2 and neoplasm: In cervical cancer, AL441992.1, LINC01305, AL354833.2, lncRNA CNNM3-DT and lncRNA SCAT2 can promote cuproptosis to protect the body from tumor cells attack and improve tumor prognosis; while AL354733.3 and AC009902.2 can inhibit cuproptosis to facilitate tumor growth (189).